All In Biotech

Drug Trial Radar · NCT00284856

Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)

A Multicenter, Randomized, Double-Blind, Parallel-Group 6-Month Study to Evaluate the Efficacy and Safety of Oral Montelukast Sodium, Fluticasone Propionate and Placebo in Patients With Chronic Asthma Who Smoke Cigarettes

Last checked: Nov 19, 2026Latest source record: May 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,640 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,640

Actual

Start

May 2006

Primary completion

Apr 2010

Study completion Apr 2010

Sponsor

Lead sponsor
Organon and CoIndustry
Sponsor type
Industry
First posted
Feb 1, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter study to evaluate the efficacy and safety of MK0476 versus placebo in participants with chronic asthma who actively smoke cigarettes.

Conditions

  • Asthma

Interventions

  • montelukast sodiumDrug

    montelukast 10 mg tablet once daily, 6 month treatment period

  • Comparator: PlaceboDrug

    fluticasone propionate 250 mcg Placebo (Pbo) twice daily, 6 month treatment period

  • Comparator: fluticasoneDrug

    fluticasone propionate 250 mcg twice daily, 6 month treatment period

  • Comparator: PlaceboDrug

    montelukast 10 mg Pbo tablet once daily, 6 month treatment period

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Asthma-control Days Over the 6-month Treatment PeriodTime frame: 6 months

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.